Toronto, Canada · drjenniferonuora.com
Microbiome Scientist. Consultant. Advocate.
Generating knowledge that matters — from the infant gut microbiome in Bangladesh to the boardrooms and communities that shape global health.
As featured in / affiliated with
American Society for Nutrition · ICN-IUNS Paris · Gates Foundation SEPSiS Program · Cell Host & Microbe · Knight Lab, UC San Diego · University of Toronto
Scientist. Mentor. Builder.
Jennifer C. Onuora is a PhD-trained microbiome scientist, entrepreneur, and advocate whose work sits at the intersection of global child health, data science, and social impact. She completed her doctoral degree in Nutritional Sciences at the University of Toronto's Temerty Faculty of Medicine, where she achieved a perfect GPA of 4.0/4.0 and was recognised as the most outstanding doctoral graduate by her department.
Her doctoral research generated one of the most comprehensive characterisations of early-life gut microbiome development ever produced from an urban low- and middle-income country, examining over 55 mother-infant pairs across 385 stool samples and leading a 305-participant randomised controlled trial funded by the Bill and Melinda Gates Foundation. Her findings challenged prevailing assumptions about how infant gut communities develop, demonstrating that environmental and horizontal transmission rivals the vertical maternal transmission that Western-centred research had long emphasised.
Jennifer holds an MSc from Newcastle University, England (Commonwealth Master's Scholarship, awarded to fewer than 1% of international applicants globally), and a BSc in Biotechnology with First Class Honours from Ebonyi State University, Nigeria, where she was recognised as Best Graduating Student. In secondary school, she received the Overall Best in Sciences Award and the Exceptional Scholars Award for a record-breaking score in the Nigerian Diocesan Council examinations in 2012.
Beyond research, Jennifer is the founder of Ellveris, a mentorship and women's health platform expanding globally, and serves as a pro bono consultant through Verax Partners. She is a Research and Development Scientist at Vitract, where she leads bioinformatics infrastructure and clinical evidence generation, and is actively pursuing a postdoctoral fellowship focused on maternal and child health.
Every claim grounded in evidence. Every analysis built to withstand scrutiny.
Science that stays in journals is science half-finished. The measure is what changes.
The populations most underserved by research deserve the most rigorous attention.
Understanding the earliest days of human microbial life.
Jennifer's doctoral research addressed one of the most consequential blind spots in microbiome science: the near-complete absence of longitudinal data from urban low- and middle-income countries, where the burden of neonatal mortality is highest and the evidence gap most consequential.
Infant and Maternal Microbiome Dynamics and the Effects of Lactiplantibacillus plantarum on the Infant Gut Microbiome in Dhaka, Bangladesh
Age-related trajectories of the infant fecal, oral, and skin microbiome and associations with prenatal and postnatal factors in Dhaka, Bangladesh.
Manuscript in Preparation · Expanding to Include MetabolomicsEnvironmental and maternal imprints on infant gut metabolic development. Published in Cell Host & Microbe (2025) — one of the top three journals in microbiology globally. Co-first author.
Published · Cell Host & Microbe 2025Effects of early neonatal administration of Lactiplantibacillus plantarum ATCC 202195 on the fecal microbiome and metabolome of infants in Dhaka, Bangladesh — a 305-participant, 3-arm randomised controlled trial.
Manuscript in Preparation"Shared environmental exposures and horizontal transmission are equally important drivers of infant microbial colonisation as vertical maternal transmission — a paradigm-shifting finding for how microbiome-targeted interventions should be designed in LMICs."
"Probiotic effects were transient and context-specific, determined by the pre-existing ecological structure of the gut microbiome, establishing that interventions proven in one setting cannot be assumed effective in another."
"Among the most densely sampled infant microbiome cohorts reported from a low- and middle-income country to date... I judge the thesis to meet and exceed the standards expected for the PhD degree. As such, I believe this thesis meets the standard of excellence for consideration for a dissertation award."
— Dr. Marie-Claire Arrieta, UCalgary Research Excellence Chair
Science-driven strategy for organisations that want to lead.
Jennifer brings doctoral-level expertise in microbiome science, clinical research, data analytics, and scientific communication to organisations navigating complex evidence landscapes. Her consulting spans life sciences, health tech, social impact, and brand strategy.
Drafting and editing research proposals, NIH/CIHR-style grants, technical white papers, and manuscripts for biotech and academic clients. Built on a track record of peer-reviewed publications in top-tier journals.
Microbiome data analysis, multi-omics integration, statistical modelling, and custom bioinformatics pipelines. Expert in R, Python, QIIME2, HUMAnN3, MetaPhlAn4, and reproducible workflow development.
Study design, protocol development, RCT coordination, secondary analysis, and regulatory submissions. Experienced across multi-site international clinical programs.
Translating complex science into clear strategies, HCP communications, and funded outcomes for biotech, health tech, and academic clients. Tailored for diverse audiences from clinicians to investors.
Positioning, data storytelling, and product narratives for early-stage life science and health ventures. Helping founders and scientists articulate their vision and communicate with clarity across web, pitch, and investor materials.
Advising organisations on how to use evidence strategically — for positioning, policy, funding, and impact. Connecting scientific findings to business and social outcomes.
Jennifer serves as a pro bono consultant through Verax Partners, applying her research and strategic expertise to mission-driven organisations that operate in resource-constrained environments.
Jennifer's consulting engagements are selective and collaborative. Reach out to discuss your project, timeline, and how her expertise can serve your goals.
Get In TouchFor the girl who was told the world wasn't built for her.
Jennifer speaks on the intersection of science, equity, and ambition — drawing on her journey from Ebonyi State, Nigeria to the world's leading research institutions. Her talks are grounded in data, personal narrative, and an unshakeable belief that representation and rigour are not in tension.
Jennifer is the founder of Ellveris (ellveris.com), a mentorship and women's health platform she established to support underprivileged Nigerian and African girls through education, career guidance, and personal development. Ellveris is now expanding globally to scale access to mentorship and women's health resources worldwide.
Jennifer received a United Nations recognition for her voluntary contributions to the Sustainable Development Goals in Nigeria in 2018, with particular focus on SDG 3 (Good Health and Well-Being), SDG 4 (Quality Education), and SDG 5 (Gender Equality). She is a longstanding advocate for girl child education in the African context.
Throughout her career, Jennifer has mentored prospective African graduate students through the Exceptional Scholars Academy, undergraduate students through the University of Toronto's Nutritional Sciences Mentorship Program, and secondary school girls as a senior biology teacher and mentor in Nigeria.
"Science that doesn't reach the people who need it most is science that hasn't finished its job."
— Jennifer C. Onuora
For research collaborations, consulting enquiries, speaking invitations, or media requests.